SH

Stuart Henderson

VP, Corporate Development & Investor Relations at Passage Bio

Stuart Henderson has extensive experience in corporate development, investor relations, and marketing within the biotechnology and healthcare sectors. Currently serving as Chief Business Officer at Passage Bio, Stuart has previously held senior roles including Senior Vice President of Corporate Development & Investor Relations and Vice President of Corporate Development & Investor Relations. At TELA Bio, Stuart contributed as Vice President of Corporate Development and Investor Relations, as well as Vice President of Marketing and Senior Director of Marketing. Stuart's career began with analytical roles at Quaker Partners and consultancy work at ZS Associates. Stuart holds a Bachelor of Arts in Biological Sciences from Cornell University.

Location

Philadelphia, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices


Passage Bio

1 followers

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).


Industries

Employees

51-200

Links